Verge Genomics Names Robert Scannevin, Chief Scientific Officer
Verge Genomics, a drug discovery company developing therapies for neurological diseases by integrating a unique all-in-human genomic platform with machine learning, announced today that Robert Scannevin, Ph.D., will join the company as Chief Scientific Officer. Reporting directly to Alice Zhang,…
Gene-editing Company Kiromic Announces 6 Posters Presented at AACR
Gene-editing Company Kiromic Announces 6 Posters Presented at AACR
Kiromic BioPharma, Inc. (Nasdaq: KRBP), an immuno-oncology target discovery and gene-editing company, with a proprietary artificial intelligence neural network platform...
Deep Genomics Appoints Jeffrey M. Brown, VP Preclinical Research
Deep Genomics Appoints Jeffrey M. Brown, VP Preclinical Research
Deep Genomics, the leading artificial intelligence (AI) therapeutics company, announced today the appointment of Jeffrey Brown, Ph.D., Vice President, Preclinical...
EchelonDx and Cradle Genomics Join Forces
EchelonDx and Cradle Genomics Join Forces
Complementary technologies will transform data analysis and reporting capabilities for prenatal diagnostic testing Echelon Diagnostics, Inc., a leading provider of...
Gene Therapy Developer Capsida Biotherapeutics Debuts with $140M
Gene Therapy Developer Capsida Biotherapeutics Debuts with $140M
– Versant, Westlake Village BioPartners launch next-generation gene therapy company with $50 million Series A – – Collaboration with AbbVie...